By Business/Source
Currency:INR
2026/Q3
Stock NameRevenueRatio
Pharmaceuticals67.46B95.36%
New Ventures3.81B5.39%
Inter segment revenue-534M-0.75%
By Country/Region
Currency:INR
2020/FY
Stock NameRevenueRatio
India67.41B40.38%
Rest of the World43.11B25.82%
United States of America38.74B23.20%
South Africa22.06B13.22%
Other Operating Revenue-4.37B-2.62%